IRON - Disc Medicine, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$103.33
DETAILS
HIGH:
$125.00
LOW:
$80.00
MEDIAN:
$105.00
CONSENSUS:
$103.33
UPSIDE:
54.64%
About Disc Medicine, Inc. (https://www.discmedicine.com)
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| John D. Quisel | Chief Executive Officer, President & Director | 1971 | $1,259,763 USD |
| Jean Franchi | Chief Financial Officer | 1966 | $838,980 USD |
| William Jacob Savage | Chief Medical Officer | 1974 | $836,840 USD |
| Pamela Stephenson | Chief Commercial Officer | 1968 | $832,100 USD |
| Jonathan Yu | Chief Opearating Officer | 1981 | $811,560 USD |
| Donald William Nicholson | Executive Chairman | 1958 | $170,000 USD |
| Brian MacDonald | Founder & Chair of Scientific Advisory Board | 1961 | $88,542 USD |
| Hua Yang | Senior Vice President & Head of Early Development and Clinical Pharmacology | – | – |
| Joseph Beaulieu | Senior Vice President of Finance | 1981 | – |
| Lisa Amaya Price | Chief Human Resources Officer | – | – |
| Rahul Khara | Chief Legal Officer & Secretary | 1982 | – |
| Rahul Rajan Kaushik | Chief Technical Officer | – | – |
| Sonia Razzetti | Senior Vice President of Quality | – | – |
| Srikanth Venkatraman | Senior Vice President & Head of Chemistry | – | – |
| Steven Caffé | Chief Regulatory Officer | 1960 | – |